Choom™ (CSE: CHOO; OTCQB: CHOOF) Announces Specialty Medijuana Products Inc. Receives Cultivation License from Health Canada for Expansion Facility
Marijuana Stocks, Finance, & Investing May 21, 2019 0
Choom™ (CSE: CHOO; OTCQB: CHOOF) Announces Specialty Medijuana Products Inc. Receives Cultivation License from Health Canada for Expansion Facility
Specialty Medijuana Products Inc. (“SMP”), of which Choom Holdings Inc. is a 9.8% equity stakeholder, has received a cultivation license on an additional and contiguous site in Sooke, B.C. The license was issued and effective on May 17, 2019.
Organigram Announces May 21st as Inaugural Date of Trading on the Nasdaq Global Select Market
Marijuana Stocks, Finance, & Investing May 17, 2019 0
Organigram Announces May 21st as Inaugural Date of Trading on the Nasdaq Global Select Market
Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), announces that its common shares will commence trading on the Nasdaq Global Select Market under the symbol “OGI” on Tuesday May 21, 2019.
Green Growth Brands Completes C$61.2 Million Financing Led By Strategic Investors
Marijuana Stocks, Finance, & Investing May 17, 2019 0
Green Growth Brands Completes C$61.2 Million Financing Led By Strategic Investors
Green Growth Brands, Inc. (CSE: GGB) (OTCQB: GGBXF) has raised gross proceeds of US$45.5 million (C$61,233,100)
Analyzing Some Exciting but Unknown Marijuana Stocks
Marijuana Stocks, Finance, & Investing May 16, 2019 0
Analyzing Some Exciting but Unknown Marijuana Stocks
The growth of the marijuana industry looks likely to continue.
InMed Pharmaceuticals Reports Third Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update
Marijuana Stocks, Finance, & Investing May 16, 2019 0
InMed Pharmaceuticals Reports Third Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update
InMed Pharmaceuticals Inc. (TSX:IN;OTCQX:IMLFF), a biopharmaceutical company developing a proprietary biosynthesis platform technology for the manufacturing of pharmaceutical-grade cannabinoids as well as an R&D pipeline of medications targeting diseases with high unmet medical needs, reported financial results for the three and nine months ended March 31, 2019.
Aurora Cannabis Announces Financial Results for the Third Quarter of Fiscal 2019 Showing Solid Net Revenue Growth
Marijuana Stocks, Finance, & Investing May 16, 2019 0
Aurora Cannabis Announces Financial Results for the Third Quarter of Fiscal 2019 Showing Solid Net Revenue Growth
Aurora Cannabis Inc. (NYSE:ACB) (TSX: ACB), announced its financial and operational results for the third quarter ended March 31st, 2019
1933 Industries Announces USD$10.45 Million Sale of its Cultivation Real Estate Asset in Las Vegas with a 10-Year Lease-Back
Marijuana Stocks, Finance, & Investing May 16, 2019 0
1933 Industries Announces USD$10.45 Million Sale of its Cultivation Real Estate Asset in Las Vegas with a 10-Year Lease-Back
1933 Industries Inc.(CSE: TGIF) (OTCQX: TGIFF) a licensed cultivator and producer of cannabis flower and concentrates and manufacturer of hemp/CBD wellness products, is pleased to announce that its subsidiary, Alternative Medicine Association, has completed a sale and lease back for its newly constructed cannabis cultivation facility in Las Vegas, Nevada.
SLANG Worldwide to Acquire Award-Winning Cannabis Brands and Additional US Distribution in Strategic Acquisition of LBA Global Corporation
Marijuana Stocks, Finance, & Investing May 15, 2019 0
SLANG Worldwide to Acquire Award-Winning Cannabis Brands and Additional US Distribution in Strategic Acquisition of LBA Global Corporation
SLANG Worldwide Inc. (CNSX: SLNG), (Frankfurt: 84S), has entered into an agreement to acquire LBA Global Corporation and its Lunchbox Alchemy brand portfolio and subsidiary Hydra Distribution
Indus Holdings, Inc. Acquires W Vapes
Indus Holdings, Inc. (CSE: INDS), announced that it has signed a definitive agreement to acquire the assets of W The Brand (“W Vapes”), a multi-state manufacturer and distributor of cannabis concentrates, cartridges and disposable pens
Cronos Group and MediPharm Labs Enter $30 Million Multi-Year Private Label Cannabis Concentrate Supply Agreement with Potential to Increase to $60 Million
Marijuana Stocks, Finance, & Investing May 15, 2019 0
Cronos Group and MediPharm Labs Enter $30 Million Multi-Year Private Label Cannabis Concentrate Supply Agreement with Potential to Increase to $60 Million
MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) has entered into a multi-year supply agreement with Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON).